Dallas, Texas (PRWEB) December 23, 2013
The global microfluidicsmarket is valued at an estimated $1.59 billion in 2013 and is expected to grow at a CAGR of 17.6% in the next five years.
The global microfluidics marketis categorized into materials, products, and applications segments. This report studies the market trends for the above mentioned segments in three industries, namely, pharmaceutical, in-vitro diagnostics, and drug delivery devices.Based on materials, the market is classified into polymers, silicon, glass, and other materials. Based on products, the pharmaceutical market is categorized into microfluidic chips for lab analytics, accurate dispensing devices, and microreactors for drug synthesis. The in-vitro diagnostics segment is further segmented into clinical diagnostics, Point-of-Care, environmental testing, industrial testing, and agro food testing. The drug delivery devices market is categorized into inhaler nozzles, micro needles, and micro pumps.
Complete report is available at http://www.rnrmarketresearch.com/microfluidics-market-by-materials-polymers-silicon-glass-pharmaceuticals-microreactors-toxicity-screening-lab-on-chip-proteomic-genomic-analysis-drug-delivery-devices-microneedles-microp-market-report.html.
The rising demand for POC diagnostic devices, quick return on investments offered by microfluidics devices which helps in cost reductions, and miniaturization of microfluidic chips will be the major drivers for this market.However, factors such as difficulty in incorporatingemerging microfluidic technologies into existing workflows and presence of complex and time consuming regulatory standards are hampering the market growth. Recent developments in drug delivery technologies such as microfluidic micropumps and microneedles are encouraging the growth of the microfluidics market. The in-vitro diagnostics segment commands the largest share of the microfluidics products market in 2013. However, the drug delivery devices segment is estimated to grow at the highestCAGR of 24.5% during the study period.
Factors such as reduced costs, driven by the low sample consumption, are demanding the adoption of microfluidic micropumps. The enhanced efficacy of transdermal delivery of macromolecules for treating various diseasesis a major factor driving the growth of themicroneedles market.The breakthrough discovery of injecting macromolecules transdermally is in turn favoring the growth of the API (Active Pharmaceutical Ingredient) market, which is boosting the adoption rate of microneedles.
Major players in the microfluidics market include Abbott Laboratories (U.S.), Agilent Technologies (U.S.), Caliper Life Sciences (PerkinElmer) (U.S.), Cepheid (U.S.), DanaherCorporation (U.S.), Life Technologies Corporation (U.S.), and Roche Diagnostics (Germany). A majority of companies in the microfluidics market are from the U.S.
Major Point of table of content
10 Company Profiles
10.1 Abbott Laboratories, Inc.
10.2 Agilent Technologies
10.3 Perkinelmer, Inc.
10.4 Bartels Mikrotechnik GMBH
10.5 Scienion AG
10.6 Cepheid, Inc.
10.7 Fluidigm Corporation
10.8 Raindance Technologies
10.9 Becton, Dickinson And Company 1 Becton Drive
10.10 Bio-Rad Laboratories, Inc.
10.11 Biofluidix GMBH
10.12 Danaher Corporation
10.13 Johnson & Johnson
10.14 Life Technologies Corporation
10.15 Microfluidic Chipshop GMBH
10.16 Roche Diagnostics Limited
10.17 Siemens Healthcare
Purchase a copy of this report at http://www.rnrmarketresearch.com/contacts/purchase?rname=136837.
Browse more reports on Medical Devices Reports at http://www.rnrmarketresearch.com/reports/life-sciences/medical-devices.
RnRMarketResearch.com is an online database of market research reports offer in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.